Tseng, Ho-Hsing <br/><br/>
Securin enhances the anti-cancer effects of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075) in human colorectal cancer cells.  [electronic resource] 

 -  PloS one  2012 
 - e36006 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0036006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>CDC2 Protein Kinase--metabolism<br/>Caspases--metabolism<br/>Colorectal Neoplasms--metabolism<br/>DNA Repair--drug effects<br/>G2 Phase Cell Cycle Checkpoints--drug effects<br/>HCT116 Cells<br/>Humans<br/>Indoles--pharmacology<br/>JNK Mitogen-Activated Protein Kinases--metabolism<br/>M Phase Cell Cycle Checkpoints--drug effects<br/>Neoplasm Proteins--genetics<br/>Phosphorylation--drug effects<br/>Securin<br/>p38 Mitogen-Activated Protein Kinases--metabolism